Brief: Pure Biologics H1 Net Loss Widens To 12.0 Mln Zlotys
16/09/2022 16:08
Sept 16 (Reuters) - Pure Biologics SA PUR1.WA :
* H1 NET LOSS 12.0 MILLION ZLOTYS VERSUS LOSS 6.8 MILLION
ZLOTYS
YEAR AGO
* H1 OPERATING REVENUE 6.5 MILLION ZLOTYS VERSUS 7.1 MILLION
ZLOTYS YEAR AGO
Source text for Eikon: ID:nEM821Lpxa
Further company coverage: PUR1.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Multiqure SA
See all newsBrief: Selvita To Expand Its Operations Through New Biological Drug Business
Brief: Pure Biologics FY Net Loss Widens To 25.6 Mln Zlotys
Brief: Pure Biologics Signs Term Sheet With ACRX Investments On Potential Financing
Brief: Pure Biologics Signs Deal For Subsidy With Poland's Medical Research Agency
Brief: Pure Biologics To Seek Extra Financing For PB003 And PB004 Projects